- 1. G Antigen Family D, Protein 3
- [Expressed in testis and placenta by human GAGED3 Gene (GAGE Family, CT Family), 111-aa 12-kD XAGE3 Protein has unknown function and shares similarity with GAGE/PAGE proteins, as well as with Pyridoxal-Dependent Decarboxylase Conserved Domain (C. elegans) and Larval Locomotory Behavior Glutamate Decarboxylase (Drosophila). (NCI) ( NCI )] (UMLS (NCI) C1333657) GAGED3;
GAGED3 Protein;
XAGE-2 Protein;
XAGE3 Protein;
XAGE-3 Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 18. Ganglioneuroma of Mediastinum
- [A ganglioneuroma arising from the mediastinum. ( NCI )] (UMLS (NCI) C1334654) Ganglioneuroma of the Mediastinum;
Mediastinal Ganglioneuroma;
=Neoplastic Process |
- 2. Ganciclovir/Interleukin-2/Zidovudine
- (UMLS (NCI) C0935687) =Therapeutic or Preventive Procedure
| - 19. Ganglioneuroma of Retroperitoneum
- [A ganglioneuroma arising from the retroperitoneum. ( NCI )] (UMLS (NCI) C1335775) Ganglioneuroma of the Retroperitoneum;
Retroperitoneal Ganglioneuroma;
=Neoplastic Process ;
|
- 3. GANG VENTRAL HERNIA NEC
- [ ] (UMLS (ICD9CM) C0156123) =Acquired Abnormality; Disease or Syndrome
| - 20. Ganglioneuromatosis
- (UMLS (NCI) C0334595) =Neoplastic Process
|
- 4. gangliocyte
- [nerve cell body in a sensory or autonomic ganglion of the peripheral nervous system. ( CSP )] (UMLS (CSP) C0228071) =Cell = ;
ganglion | - 21. ganglionic blocking agent
- [group of agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons; because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. ( CSP )] (UMLS (CSP) C0017076) =Pharmacologic Substance ;
=neuropharmacologic agent;
=hexamethonium compound;
tetraethylammonium compound;
|
- 5. Gangliocytic Intestinal Paraganglioma
- [A usually indolent, extra-adrenal paraganglioma affecting the intestine. Patients may present with gastrointestinal hemorrhage. Unlike the conventional paragangliomas, this tumor has a peculiar morphologic appearance; it consists of a mixture of epithelioid neuroendocrine cells, Schwann-like cells, and ganglion cell-like elements. ( NCI )] (UMLS (NCI) C1334232) Gangliocytic Paraganglioma of Intestine;
Gangliocytic Paraganglioma of the Intestine;
Intestinal Gangliocytic Paraganglioma =Neoplastic Process | - 22. ganglioside
- [subclass of acidic glycosphingolipids containing one or more sialic acid residues. ( CSP )] (UMLS (NCI) C0017082) =Lipid; Biologically Active Substance =asialoganglioside;
|
- 6. Gangliocytoma
- [A well differentiated, slow growing neuroepithelial neoplasm composed of neoplastic, mature ganglion cells. (Adapted from WHO.) ( NCI )] (UMLS (NCI) C0017075) =Neoplastic Process ;
=Neoplasm of Neuroepithelial Tissue;
| - 23. Ganglioside Biosynthesis
- [The chemical reactions and pathways resulting in the formation of ceramide oligosaccharides carrying in addition to other sugar residues, one or more sialic acid residues. [ISBN:0198506732 "Oxford Dictionary of Biochemistry and Molecular Biology"] ( GO )] (UMLS (NCI) C1157367) Ganglioside Biosynthesis Pathway =Molecular Function
|
- 7. ganglioglioma
- [A well differentiated, slow growing neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and neoplastic glial cells. Some gangliogliomas show anaplastic features in their glial component and are considered to be WHO grade III. Rare cases of newly diagnosed gangliogliomas with grade IV (glioblastoma) changes in the glial component have also been reported. (Adapted from WHO.) ( NCI )] (UMLS (CSP) C0206716) =Neoplastic Process =glial cell tumor;
| - 24. Ganglioside GD2-KLH
- [A cancer vaccine containing an epitope of glycosphingolipid GD2 conjugated with the immunostimulant Keyhole Limpet Hemocyanin (KLH), with potential antineoplastic activity. The disialoganglioside GD2 is a tumor associated antigen expressed on the surface of several cancers, including neuroblastoma medulloblastomas, astrocytomas, melanomas, small-cell lung cancer, osteosarcomas and other soft tissue sarcomas. Vaccination with GD2-KLH vaccine may elicit antibody production against cells expressing GD2 ganglioside, thereby reducing tumor cell growth. ( NCI )] (UMLS (NCI) C0338229) =Organic Chemical; Pharmacologic Substance ;
|
- 8. ganglion
- [any group of sensory or autonomic nerve cell bodies located outside the central nervous system. ( CSP )] (UMLS (CSP) C0017067) =Body Part, Organ, or Organ Component ;
=Body System, Neurologic;
=autonomic ganglion;
dorsal root ganglion;
retinal ganglion;
gangliocyte;
| - 25. Ganglioside GM2
- [A glycosphingolipid antigen expressed by a variety of human cancer cells. GM2 containing vaccines have been shown to elicit antibodies production in melanoma patients without deleterious effects associated with an immune response to GM2. Mutations in at least 1 of 3 recessive genes: HEXA, HEXB, and GM2A cause defects in GM2 catabolism, leading to lysosomal lipid storage disorders that manifest primarily as neurodegenerative diseases, including Tay-Sach's and Sandhoff Disease. ( NCI )] (UMLS (NCI) C0016896) =Lipid; Biologically Active Substance
|
- 9. Ganglion and cyst of synovium, tendon, and bursa
- [ ] (UMLS (ICD9CM) C0349693) =Disease or Syndrome
| - 26. gangliosidosis GM2 type I
- [autosomal recessive inherited gangliosidosis characterized by the onset in the first 6 months of life of an exaggerated startle response, delay in psychomotor development, hypotonia (followed by spasticity), visual loss, and a macular cherry red spot; hexosaminidase A is deficient, leading to the accumulation of GM2 ganglioside in neurons of the central nervous system and retina; this condition is strongly associated with Ashkenazic Jewish ancestry. ( CSP )] (UMLS (CSP) C0039373) =Disease or Syndrome =Gangliosidoses;
enzyme deficiency;
Gangliosidoses GM2;
|
- 10. Ganglion joint/tendon
- (UMLS (ICPC) C0497283) (Ganglion joint/tendon; KISTE SINOBIALA; Ganglion led/sene; Ganglion gewricht/pees; NIVELEN/JANTEEN GANGLIO; Kyste synovial/tendon; Ganglion/Ueberbein Gelenk/Sehne; ganglion shel perek o gid; izuleti/in ganglion; Cisti articolare/tendinea; GANGLION LEDD/SENE; Quisto sinovial articular/tendao; Ganglion en articulac/tendon; GANGLION LED/SENA) =Disease or Syndrome =musculoskeletal; Diagnosis/Diseases Component
| - 27. gangliosidosis GM2 type II
- [autosomal inherited disease caused by deficiency of the enzymes hexosaminidase A and B which leads to an accumulation of GM2 ganglioside and the sphingolipid globoside in neurons and other organs; clinical manifestations resemble Tay-Sachs disease. ( CSP )] (UMLS (CSP) C0036161) =Disease or Syndrome ;
=Gangliosidoses;
enzyme deficiency;
Gangliosidoses GM2;
|
- 11. GANGLION NOS
- [Nodular tumor-like lesions or mucoid flesh, arising from tendon sheaths, LIGAMENTS, or JOINT CAPSULE, especially of the hands, wrists, or feet. They are not true cysts as they lack epithelial wall. They are distinguished from SYNOVIAL CYSTS by the lack of communication with a joint cavity or the SYNOVIAL MEMBRANE. ( MSH )] (UMLS (ICD9CM) C1258666) Ganglion, unspecified =Acquired Abnormality; Disease or Syndrome ;
| - 28. GANGOSA
- (UMLS (ICD9CM) C0276009) =Disease or Syndrome
|
- 12. GANGLION OF JOINT
- (UMLS (ICD9CM) C0158334) =Disease or Syndrome
| - 29. GANGR INCISIONAL HERNIA
- [ ] (UMLS (ICD9CM) C0156122) =Acquired Abnormality; Disease or Syndrome
|
- 13. Ganglion of Scarpa
- (UMLS (NCI) C0036286) =Body Part, Organ, or Organ Component
| - 30. GANGR VENTRAL HERNIA NOS
- [ ] (UMLS (ICD9CM) C0156120) =Acquired Abnormality; Disease or Syndrome
|
- 14. GANGLION OF TENDON
- (UMLS (ICD9CM) C0158335) =Acquired Abnormality
| - 31. gangrene
- [death and decay of body tissue, often occurring in a limb, caused by insufficient blood supply and usually following injury or disease. ( CSP )] (UMLS (CSP) C0017086) =Disease or Syndrome ;
=necrosis;
|
- 15. Ganglionectomy
- [Removal of an autonomic or sensory ganglion by any means. ( MSH )] (UMLS (NCI) C0017074) =Therapeutic or Preventive Procedure ;
| - 32. Ganirelix Acetate
- [The acetate salt form of ganirelix, a synthetic decapeptide with high antagonistic activity against naturally occurring gonadotropin-releasing hormone (GnRH). Ganirelix directly competes with the GnRH for receptor binding in the anterior pituitary gland, thus induces a rapid and reversible suppression of the release of follicle stimulating hormone (FSH) and luteinizing hormone (LH). This agent is used for the inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation, and in combination with other hormones for retrieval of the mature follicles for in-vitro fertilization. ( NCI )] (UMLS (NCI) C0872894) GANIRELIX ACETATE PREPARATION;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance =ganirelix;
=GANIRELIX ACETATE 250 MCG/0.5ML;
|
- 16. Ganglioneuroblastoma
- [A neuroblastic tumor characterized by the presence of neuroblastic cells, ganglion cells, and a stroma with Schwannian differentiation which constitutes more than fifty-percent of the tumor volume. There are two histologic subtypes identified: ganglioneuroblastoma, intermixed and ganglioneuroblastoma, nodular. ( NCI )] (UMLS (NCI) C0206718) =Neoplastic Process =neuroblastoma;
| - 33. GANT
- [GIST. A type of tumor that usually begins in cells in the wall of the gastrointestinal tract. It can be benign or malignant. ( NCI )] (UMLS (NCI) C0238198) =Neoplastic Process ;
|
- 17. Ganglioneuroblastoma of Mediastinum
- [A ganglioneuroblastoma arising from the mediastinum. ( NCI )] (UMLS (NCI) C1334653) Ganglioneuroblastoma of the Mediastinum;
Mediastinal Ganglioneuroblastoma;
=Neoplastic Process | - 34. Gantrisin
- (UMLS (NCI) C0728838) =Organic Chemical; Pharmacologic Substance
|
home
